pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital clinical programs — 1136 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
First People's Hospital projects
1,136 ClinicalTrials.gov programs sponsored by First People's Hospital.
First People's Hospital has 1,136 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
prescribing anapproved drug, examination
The First People's Hospital of Lianyungang
Irritable Bowel Syndrome With Diarrhea
1 trial -
profound neuromuscular blockade
The First People's Hospital of Lianyungang
Profound Muscle Relaxation
1 trial -
quetiapine fumarate tablet (Seroquel)
The First People's Hospital of Lianyungang
Bipolar Disorder
1 trial -
rhGM-CSF group
The First People's Hospital of Lianyungang
Mycoses
1 trial -
rhTPO
The First People's Hospital of Lianyungang
Primary Immune Thrombocytopenia
1 trial -
rhTPO
The First People's Hospital of Lianyungang
Thrombocytopenia
1 trial -
rituximab combined with corticosteroids
The First People's Hospital of Lianyungang
Primary Membranous Nephropathy
1 trial -
ropivacaine
The First People's Hospital of Lianyungang
Injury of Upper Limb
1 trial -
semaglutide combined with metformin
The First People's Hospital of Lianyungang
Osteoporosis
1 trial -
sodium zirconium cyclic silicate
The First People's Hospital of Lianyungang
Potassium Imbalance
1 trial -
ticagrelor
The First People's Hospital of Lianyungang
Inflammation
1 trial -
1.0 /2024.05.01
The First People's Hospital of Lianyungang
Gastrointestinal Stromal Tumors
1 trial -
18F-FDG
The First People's Hospital of Lianyungang
Tumor, Solid
1 trial -
2020C03018
The First People's Hospital of Lianyungang
Coronary Microvascular Disease
1 trial -
2023-SR-508
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
2024474
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
2025ZSLYEC-365
The First People's Hospital of Lianyungang
Anal Fistula
1 trial -
68Ga-DOTA-NT-20.3
The First People's Hospital of Lianyungang
Pancreatic Ductal Adenocarcinoma
1 trial -
68Ga-Her2-affibody
The First People's Hospital of Lianyungang
Neoplasms
1 trial -
89Zr-KN035
The First People's Hospital of Lianyungang
Solid Tumor, Adult
1 trial -
99mTc-H7ND SPECT/CT imaging performed
The First People's Hospital of Lianyungang
NSCLC
1 trial -
A2023519
The First People's Hospital of Lianyungang
Anemia
1 trial -
ASC09/ritonavir group
The First People's Hospital of Lianyungang
2019-nCoV
1 trial -
ATRA+Venetoclax+Azacitidine
The First People's Hospital of Lianyungang
AML, Adult
1 trial -
Acalabrutinib
The First People's Hospital of Lianyungang
Chronic Lymphocytic Leukemia
1 trial -
Accurate Prediction Artificial Intelligence Models
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Adjustment of Antiplatelet Drugs
The First People's Hospital of Lianyungang
Intracranial Aneurysm
1 trial -
Albuterol
The First People's Hospital of Lianyungang
Chronic Obstructive Pulmonary Disease
1 trial -
Amberen
The First People's Hospital of Lianyungang
Climacteric Syndrome
1 trial -
Ambrisentan
The First People's Hospital of Lianyungang
Pulmonary Arterial Hypertension
1 trial -
Anlotinib Hydrochloride
The First People's Hospital of Lianyungang
Non-Small-Cell Lung
1 trial -
Anlotinib hydrochloride
The First People's Hospital of Lianyungang
Non-Small-Cell Lung Cancer
2 trials -
Anti-HER2 CAR-T cells
The First People's Hospital of Lianyungang
HER2-positive Advanced Malignant Solid Tumors
1 trial -
AntiPlatelet therapy
The First People's Hospital of Lianyungang
Coronary Artery Disease
1 trial -
Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
The First People's Hospital of Lianyungang
Ovarian Cancer
1 trial -
Aspirin
The First People's Hospital of Lianyungang
Anterior Ischemic Optic Neuropathy
1 trial -
Atorvastatin
The First People's Hospital of Lianyungang
Contrast-induced Acute Kidney Injury
1 trial -
Atorvastatin 20 Mg Oral Tablet
The First People's Hospital of Lianyungang
Atherosclerotic Cardiovascular Disease
1 trial -
Atorvastatin Calcium 20Mg Tab
The First People's Hospital of Lianyungang
Hyperlipidemias
1 trial -
BCL regimen
The First People's Hospital of Lianyungang
Peripheral T-cell Lymphoma
1 trial -
BCMA-CART
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
BRL-101
The First People's Hospital of Lianyungang
Sickle Cell Disease
1 trial -
Bactoblis
The First People's Hospital of Lianyungang
Oral Disease
1 trial -
Basic treatment
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Best medical management
The First People's Hospital of Lianyungang
Stroke, Ischemic
1 trial -
Bevacizumab
The First People's Hospital of Lianyungang
Brain Glioma
1 trial -
Bifidobacterium
The First People's Hospital of Lianyungang
Depressive Disorder
1 trial -
Bivalirudin
The First People's Hospital of Lianyungang
ST-segment Elevation Myocardial Infarction (STEMI)
1 trial
Frequently asked questions
How many clinical projects does First People's Hospital have?
1,136 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.